U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279428) titled 'A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors' on Dec. 01.
Brief Summary: This study is an open, multicenter, non-randomized phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of BL-M24D1 for Injection in patients with locally advanced or metastatic gastrointestinal tumors and other solid tumors.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Gastrointestinal Tumors
Solid Tumors
Intervention:
DRUG: BL-M24D1
Administration by intravenous infusion for a cycle of 2 weeks.
Re...